Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)

SHA:605369 Revenue

Zhejiang Gongdong Medical Technology had revenue of 307.85M CNY in the quarter ending September 30, 2026, with 6.83% growth. This brings the company's total for the last twelve months to 1.19B, up 5.54% year-over-year. In the year 2025, Zhejiang Gongdong Medical Technology had annual revenue of 1.14B with 1.84% growth. That makes Zhejiang Gongdong Medical Technology the 18,311th largest company in the world by revenue and 3,340th in China.

• Revenue (ttm): 1.19B
• Revenue Growth: +5.54%
• P/S Ratio: 3.20
• Revenue / Employee: n/a
• Employees: 1,659
• Market Cap: 3.83B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Testing 480.52M 43.1%
• Blood Collection 279.60M 25.1%
• Collection 138.55M 12.4%
• Medical Care 90.53M 8.1%
• Commerce 43.32M 3.9%
• Others 42.59M 3.8%
• Pharmaceutical Packaging 40.63M 3.6%

By Geography

Chart

• China 939.40M 78.3%
• Overseas 260.99M 21.7%

Fiscal year ended Dec 31, 2025 See the full SHA:605369 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.14B	20.49M	1.84%
Dec 31, 2024	1.12B	140.13M	14.37%
Dec 31, 2023	975.08M	-493.60M	-33.61%
Dec 31, 2022	1.47B	274.43M	22.98%
Dec 31, 2021	1.19B	364.60M	43.95%

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error